Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05646134

Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Upper Extremity Motor Function in Stroke Patients

Led by Lithuanian University of Health Sciences · Updated on 2022-12-12

150

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This clinical trial aims to evaluate the effects of repetitive transcranial magnetic stimulation (rTMS) on upper extremity motor function in stroke patients. The main questions it seeks to answer are: 1. Whether repetitive transcranial magnetic stimulation (rTMS) has a positive effect on upper extremity motor function in stroke patients. 2. Which stimulation protocol (low frequency - LF or high-frequency - HF) has better outcomes for improving upper extremity motor function in stroke patients? Participants will receive 10 procedures of repetitive transcranial magnetic stimulation (rTMS) over two weeks. They will be randomly assigned into low-frequency, high-frequency rTMS groups or sham stimulation groups. Upper extremity motor function will be evaluated twice: before stimulation and 3-4 weeks after stimulation. Researchers will compare sham stimulation to see if it has the same or better outcomes for improving upper extremity motor function in stroke patients than real rTMS.

CONDITIONS

Official Title

Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Upper Extremity Motor Function in Stroke Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Ischemic stroke of the middle cerebral artery confirmed by CT or MRI
  • Acute hemiplegia or hemiparesis with hand motor deficit and muscle strength  4 on the Lovett scale
  • Time since stroke is no more than 1 month
  • No severe cognitive function deficits
Not Eligible

You will not qualify if you...

  • Implanted ferromagnetic or metal devices sensitive to magnetic fields in the head or neck, cochlear implants, neurostimulators, pacemakers, or drug delivery pumps
  • Complete aphasia or severe cognitive impairment
  • Use of tricyclic antidepressants, neuroleptics, or benzodiazepines
  • Previous skull fractures or head injuries with loss of consciousness
  • History of epilepsy or seizures
  • Upper limb spasticity greater than Ashworth scale 2b
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Lithuanian University of Health Sciences

Kaunas, Lithuania, 44307

Actively Recruiting

Loading map...

Research Team

L

Laura Petrusevičienė, MD

CONTACT

R

Raimondas Savickas, Professor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here